drugset / Trial / NCT02483195

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

NCT02483195

Phase 4 Withdrawn University of Florida
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).

Timeline

Start
2016-08
Primary completion
2018-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Finasteride Small molecule 5 mg
Comparator Minoxidil Small molecule 5 %
Comparator Spironolactone Small molecule 200 mg

Indications